Neoprobe's gamma detection system - CE-marking:
This article was originally published in Clinica
Executive Summary
Neoprobe has CE-marked its neo2000 system, a gamma detector designed to pinpoint cancer during surgery. The Dublin, Ohio-based company says it will use the system as a platform for the launch of other intraoperative lymphatic mapping devices later this year.